Position in RLAY
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$3,811,918
+$2,717,896 QoQ
Shares Held
203,737
+85.3% QoQ
Ownership
0.093%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#84
of 256 holders
Holding Since
Sep 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in RLAY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026WELLS FARGO & COMPANY/MN holds $1,567,775,044 across 417 Biotechnology names. RLAY ranks #74 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
749,528 | $372,313,040 | |
| 2 | HALO |
Halozyme Therapeutics, Inc.
|
1,390,428 | $108,828,797 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
310,047 | $93,333,446 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
140,802 | $87,795,677 | |
| 5 | EXEL |
Exelixis, Inc.
|
717,840 | $39,057,673 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
178,780 | $33,481,916 | |
| 7 | ARGX |
Argenx SE
|
34,453 | $31,964,458 | |
| 8 | INCY |
Incyte Corp
|
255,064 | $28,914,053 |
All Filings in RLAY
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,811,918 | 203,737 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $1,094,022 | 109,952 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $1,335,766 | 157,892 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $530,038 | 101,540 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $294,030 | 84,980 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $197,846 | 75,514 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $294,271 | 71,425 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $923,706 | 130,467 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $285,608 | 43,805 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $278,307 | 33,531 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $306,617 | 27,849 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $770,271 | 91,590 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $1,773,985 | 141,241 | Shares | Defined | 2023-08-15 | |
| 2023-03-31 | $1,477,770 | 89,725 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $13,535 | 906 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $58,899 | 2,633 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $56,630 | 3,381 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $721,132 | 24,094 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $1,437,841 | 46,820 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $1,591,192 | 50,466 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $1,119,615 | 30,599 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $339,475 | 9,820 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $964,440 | 23,206 | Shares | Defined | 2021-02-09 | |
| 2020-09-30 | $1,406,151 | 33,016 | Shares | Defined | 2020-11-05 | |
| No filing history on record for this holder in this stock. | ||||||